July 20 (Reuters) – Samsung Biologics Co Ltd: * SAMSUNG BIOLOGICS TO ACQUIRE POLYPEPTIDE GROUP AG FOR 2.7 TRLN WON Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)